Drugmakers gear up for price restrictions in Biden’s legislative agenda

Wall Street Journal

25 November 2021 - Industry potentially faces significant expansion of government regulation despite success in watering down Democratic proposals.

The pharmaceutical industry is bracing for the most significant expansion of government regulation of drug prices in decades despite success in watering down proposals from congressional Democrats that would have gone much further.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder